Anti-CD11a [hu1124 (Efalizumab)]
AB00535-10.6-BT
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetITGAL
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD11a [hu1124 (Efalizumab)]
- Delivery Days Customer9
- Application Supplier NoteEfalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDhu1124 (Efalizumab)
- Gene ID3683
- Target nameITGAL
- Target descriptionintegrin subunit alpha L
- Target synonymsCD11A, LFA-1, LFA1A, integrin alpha-L, CD11 antigen-like family member A, LFA-1 alpha, LFA-1A, antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide, integrin gene promoter, integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide), leukocyte adhesion glycoprotein LFA-1 alpha chain, leukocyte function-associated molecule 1 alpha chain, lymphocyte function-associated antigen 1, alpha polypeptide
- HostHuman
- Protein IDP20701
- Protein NameIntegrin alpha-L
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203






